Additionally, the compound they have developed allows them to
profile other cancer types and see if they are dependent on BFL - 1 for their survival.
Not exact matches
Tumor
profiling can also reveal rare mutations and
other changes that make some
cancers unusually responsive to targeted drugs — knowledge that can be applied to patients with a variety of
cancer types.
«Those
profiles can tell you the different
types of
cancer; they can tell you the different
types of cells; they can distinguish stem cells from
other cells; and they can distinguish skin cells from brain cells.